The Ozempic Lawsuit is ongoing and our lawyers are accepting new clients
Therefore, semaglutide could improve other obesity-related pathologies like cardiovascular, hypertension, or fatty liver diseases
Bloodbrain barrier opening in Alzheimers disease using MR-guided focused ultrasound
This approval is an important milestone for people living with obesity and cardiovascular disease, as the SELECT data demonstrated that Wegovy has the potential to prolong lives by addressing some of the leading causes of preventable deaths by reducing the risks of cardiovascular events.
Ozempic and Rybelsus are primarily prescribed for managing type 2 diabetes, although they often lead to weight loss as a secondary effect
Nel diabete, leccesso di peso un fattore che aumenta il gi alto rischio di patologie cardiovascolari, quindi il fatto che il farmaco, oltre a tenere sotto controllo la glicemia, aiutasse anche a ridurre il peso corporeo, venne visto come un enorme successo terapeutico